Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hatem M AlAhwal"'
Autor:
Hatem M Alahwal, Yasmin Mohamed Abbas Nour, Shahida A Khan, Ahmed S Barefah, Salem M Bahashwan, Osman O Radhwi, Atheer Mousa Saeed Alzahrani, Rawan Azizullah Marouf Tash, Weam M Bajunaid, Afaf Bader Radi Alkhaldi, Abdullah T Almohammadi
Publikováno v:
Journal of Applied Hematology, Vol 14, Iss 4, Pp 300-309 (2023)
BACKGROUND: Access of blood donors to blood banks among several other factors affected rates of blood donation in many blood banks during COVID-19. Shortage of blood supply occurred to variable degrees in many countries, including Saudi Arabia. Rathe
Externí odkaz:
https://doaj.org/article/cebe67337cf04023aff55d127cfbf87e
Autor:
Osman O. Radhwi, Hamza Jan, Abdullah Waheeb, Sawsan S. Alamri, Hatem M. Alahwal, Iuliana Denetiu, Ashgan Almanzlawey, Adel F. Al-Marzouki, Abdullah T. Almohammadi, Salem M. Bahashwan, Ahmed S. Barefah, Mohamad H. Qari, Adel M. Abuzenadah, Anwar M. Hashem
Publikováno v:
Vaccines, Vol 10, Iss 2, p 151 (2022)
Introduction: Studies assessing immune responses following Pfizer-BioNTech BNT162b2 mRNA COVID-19 (Pfizer) and ChAdOx1 nCoV-19 AZD1222 (AstraZeneca) vaccines in patients with hemoglobinopathy are non-existent in the literature despite being thought a
Externí odkaz:
https://doaj.org/article/d73585190acc45b9bb1e99d47f6f78cf
Autor:
Rakan H Alelyani, Ali H Alghamdi, Thamer A Almughamisi, Abdulrahman M Alshareef, Abdulaziz N Kadasa, Amir M Alrajhi, Abdullah K Alburayk, Ahmed S Barefah, Osman O Radhwi, Abdullah T Almohammadi, Salem M Bahashawan, Hatem M AlAhwal
Publikováno v:
Cureus.
Autor:
Sami H. Alzahrani, Mohamad H. Qari, Osman O. Radhwi, Hatem M. Alahwal, Walleed H. Nasraldeen, Ahmed S. Barefah, Salem Bahashwan, Anwar M. Hashem, Edrous Alamer, Adel M. Abuzenadah, Abdulaziz Alhazmi, Abdullah T. Almohammadi, Iuliana Denetiu, Abdullah Algaissi, Sawsan S. Al-amri
Publikováno v:
International Journal of Laboratory Hematology. 44:424-429
INTRODUCTION The development of anti-platelet factor 4 (PF4) antibodies is linked to a rare thrombotic complication described now as vaccine-induced immune thrombotic thrombocytopenia (VITT). This clinical syndrome with thrombosis and thrombocytopeni
Autor:
Asma S. A Alshamarni, Galila F. Zaher, Hatem M. Alahwal, Hanadi S. Almutiry, Haneen Banjar, Salwa A. Alnajjar, Ahmed S. Barefah, Salem Bahashwan, Ghaidaa Ibraheem Almouhana, Hajar Alharbi
Publikováno v:
Health informatics journal. 27(1)
β-thalassemia is an inherited blood disorder in which the body cannot produce hemoglobin normally. Since patients with this condition receive blood transfusions regularly, iron builds up primarily in organs such as the heart, liver and endocrine gla
Autor:
Donna L. Forrest, Jennifer White, Heather J. Sutherland, Stephen H. Nantel, Alina S. Gerrie, Kevin W. Song, Maryse M. Power, Thomas J. Nevill, Cynthia L. Toze, Hatem M. Alahwal, David Sanford, Hannah M. Cherniawsky, Florian Kuchenbauer, Sujaatha Narayanan, Yasser Abou Mourad, Leo Escano
Publikováno v:
Clinical lymphoma, myelomaleukemia. 21(7)
Despite improvements in therapy, approximately 5% of patients who undergo autologous stem cell transplantation (ASCT) experience early mortality (EM), death within 1 year of transplant (EM post-ASCT). Such patients tend to have few comorbidities sugg
Autor:
Eman M. Mansory, Hatem M. Alahwal, Salem M. Bahashwan, Osman Radhwi, Abdullah T. Almohammadi, Yassir Daghistani, Jamil Al-Mughales, Ahmed S. Barefah
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 1, p 243 (2023)
Background: Antiphospholipid antibodies (aPLs) are antibodies directed against cell membrane components and can be associated with clinical features or be asymptomatic. Testing and interpreting these antibodies is associated with many challenges and
Externí odkaz:
https://doaj.org/article/ffc4746b57264bf094640fca7c36baf5
Autor:
Mohammed S. Ziyadah, Eman M. Mansory, Hatem M. Alahwal, Salem M. Bahashwan, Abdullah T. Almohammadi, Osman O. Radhwi, Talal Alghamdi, Shahida A. Khan, Majed N. Almashjary, Ahmed S. Barefah
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 20, p 6498 (2023)
Though patients with sickle cell disease (SCD) are at risk of developing venous thromboembolism (VTE), clear estimates of its incidence and predisposing factors in hospitalized SCD patients are not available. Therefore, this issue was addressed to fa
Externí odkaz:
https://doaj.org/article/e048aee181354587af56fc4a9878e8a7